Blood pressure control in Italy: Analysis of clinical data from 2005-2011 surveys on hypertension

Journal of Hypertension

Volumn 30, Issue 6, 2012, Pages 1065-1074

  Tocci, Giuliano ^a   Rosei, Enrico Agabiti ^b   Ambrosioni, Ettore ^c   Borghi, Claudio ^c   Ferri, Claudio ^d   Ferrucci, Andrea ^e   Mancia, Giuseppe ^f   Morganti, Alberto ^g   Pontremoli, Roberto ^h,i   Trimarco, Bruno ^a,j   Zanchetti, Alberto ^k   Volpe, Massimo ^a,e  

^a IRCCS NEUROMED   (Italy)

^b SPEDALI CIVILI   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f SAN GERARDO HOSPITAL   (Italy)

^g San Giuseppe Hospital   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^k UNIVERSITY OF MILAN   (Italy)

more..

Author keywords

blood pressure control; global cardiovascular risk; hypertension; hypertension surveys

Indexed keywords

ADULT; AGED; BLOOD PRESSURE REGULATION; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; OBSERVATIONAL STUDY; OUTPATIENT; PRIORITY JOURNAL; REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 84861052536     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283535993     Document Type: Review

References (57)

1. Boersma E, Keil U, De Bacquer D, De Backer G, Pyorala K, Poldermans D, et al. Blood pressure is insufficiently controlled in European patients with established coronary heart disease. J Hypertens 2003; 21:1831-1840.
2. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303: 2043-2050.
3. Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008; 336:1121-1123.
4. Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, et al. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med 2005; 165:1410-1419.
5. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363:2022-2031.
6. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358:1547-1559.
7. Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 2008; 372:1174-1183.
8. Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, et al. A calcium antagonist vs a noncalcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003; 290:2805-2816.
9. Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003; 362:782-788.
10. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-1041.
11. Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008; 359:1225-1237.
12. Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, et al. Effect of ramipril on the incidence of diabetes. N Engl J Med 2006; 355:1551-1562.
13. McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, et al. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010; 362:1477-1490.
14. Leonetti G, Cuspidi C, Facchini M. Antihypertensive therapy in the elderly: results of large trials. Ital Heart J Suppl 2001; 2:1161-1169.
15. Zanchetti A, Mancia G, Black HR, Oparil S, Waeber B, Schmieder RE, et al. Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension. J Hypertens 2009; 27:673-679.
16. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43:10-17.
17. Bramlage P, Bohm M, Volpe M, Khan BV, Paar WD, Tebbe U, Thoenes M. A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients. J Clin Hypertens (Greenwich) 2010; 12:666-677.
18. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25:1751-1762.
19. Volpe M, Tocci G, Trimarco B, Rosei EA, Borghi C, Ambrosioni E, et al. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 2007; 25:1491-1498.
20. Cuspidi C, Meani S, Lonati L, Fusi V, Magnaghi G, Garavelli G, et al. Prevalence of home blood pressure measurement among selected hypertensive patients: results of a multicenter survey from six hospital outpatient hypertension clinics in Italy. Blood Press 2005; 14:251-256.
21. Scuteri A, Coluccia R, Castello L, Nevola E, Brancati AM, Volpe M. Left ventricular mass increase is associated with cognitive decline and dementia in the elderly independently of blood pressure. Eur Heart J 2009; 30:1525-1529.
22. Benetos A, Buatois S, Salvi P, Marino F, Toulza O, Dubail D, et al. Blood pressure and pulse wave velocity values in the institutionalized elderly aged 80 and over: baseline of the PARTAGE study. J Hypertens 2010; 28:41-50.
23. Baggio B, Budakovic A, Perissinotto E, Maggi S, Cantaro S, Enzi G, Grigoletto F. Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA). Nephrol Dial Transplant 2005; 20:114-123.
24. Stramba-Badiale M, Bonazzi O, Casadei G, Dal Palu C, Magnani B, Zanchetti A. Prevalence of episodes of ST-segment depression among mild-to-moderate hypertensive patients in northern Italy: the Cardioscreening Study. J Hypertens 1998; 16:681-688.
25. Ungar A, Pepe G, Lambertucci L, Fedeli A, Monami M, Mannucci E, et al. Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertension. J Am Geriatr Soc 2009; 57:291-296.
26. Manzato E, Romanato G, Zambon S, Corti MC, Baggio G, Sartori L, et al. Metabolic syndrome and cardiovascular disease in the elderly: the Progetto Veneto Anziani (Pro.V.A. ) study. Aging Clin Exp Res 2008; 20:47-52.
27. Galassi A, Brancaccio D, Cozzolino M, Bellinghieri G, Buoncristiani U, Cavatorta F, et al. Awareness of hypertension and proteinuria in randomly selected patients in 11 Italian cities. A 2005 report of the National Kidney Foundation of Italy. J Clin Hypertens (Greenwich) 2009; 11:138-143.
28. Zanchetti A, Facchetti R, Cesana GC, Modena MG, Pirrelli A, Sega R. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens 2005; 23:2269-2276.
29. Zanchetti A, Cuspidi C, Comarella L, Rosei EA, Ambrosioni E, Chiariello M, et al. Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study. J Hypertens 2007; 25:2158-2167.
30. Cuspidi C, Valerio C, Sala C, Muiesan ML, Grandi AM, Palumbo G, et al. The Hyper-Pract Study: a multicentre survey on the accuracy of the echocardiographic assessment of hypertensive left ventricular hypertrophy in clinical practice. Blood Press 2008; 17:124-128.
31. Lonati C, Morganti A, Comarella L, Mancia G, Zanchetti A. Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study. J Hypertens 2008; 26:1801-1808.
32. Filippi A, Paolini I, Innocenti F, Mazzaglia G, Battaggia A, Brignoli O. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice. J Hum Hypertens 2009; 23:758-763.
33. Leoncini G, Viazzi F, Conti N, Baratto E, Tomolillo C, Bezante GP, et al. Renal and cardiac abnormalities in primary hypertension. J Hypertens 2009; 27:1064-1073.
34. Volpe M, Tocci G, Avogaro A, Comaschi M, Corsini A, Cortese C, et al. Committee obotES. Global Cardiovascular Risk Assessment in Different Clinical Settings: Basal Results of the EFFECTUS (Evaluation of Final Feasible Effect of Control Training and Ultra-Sensitisation) Programme. High Blood Press Cardiovasc Prev 2009; 16:55-63.
35. Cerasola G, Nardi E, Mule G, Palermo A, Cusimano P, Guarneri M, et al. Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function. Nephrology (Carlton) 2010; 15:203-210.
36. Leoncini G, Viazzi F, Rosei EA, Ambrosioni E, Costa FV, Leonetti G, et al. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study. J Hypertens 2010; 28:156-162.
37. Zaninelli A, Parati G, Cricelli C, Bignamini AA, Modesti PA, Pamparana F, et al. Office and 24-h ambulatory blood pressure control by treatment in general practice: the 'Monitoraggio della pressione ARteriosa nella medicina TErritoriale' study. J Hypertens 2010; 28:910-917.
38. Mancia G, Rosei EA, Ambrosioni E, Avino F, Carolei A, Dacco M, et al. Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study). J Hypertens 2011; 29:309-318.
39. Tocci G, Ferrucci A, Guida P, Avogaro A, Comaschi M, Corsini A, et al. An analysis of the management of cardiovascular risk factors in routine clinical practice in Italy: an overview of the main findings of the EFFECTUS study. High Blood Press Cardiovasc Prev 2011; 18: 19-30.
40. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009; 16:121-137.
41. Whyte JL, Lapuerta P, L'Italien GJ, Franklin SS. The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988-1994. J Clin Hypertens (Greenwich) 2001; 3:211-216.
42. Khan N, Chockalingam A, Campbell NR. Lack of control of high blood pressure and treatment recommendations in Canada. Can J Cardiol 2002; 18:657-661.
43. Campbell NR. Hypertension prevention and control in Canada. J Am Soc Hypertens 2008; 2:97-105.
44. Borghi C, Dormi A, D'Addato S, Gaddi A, Ambrosioni E. Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study. J Hypertens 2004; 22:1707-1716.
45. Menotti A, Lanti M, Angeletti M, Botta G, Cirillo M, Laurenzi M, et al. Twenty-year cardiovascular and all-cause mortality trends and changes in cardiovascular risk factors in Gubbio, Italy: the role of blood pressure changes. J Hypertens 2009; 27:266-274.
46. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111:1777-1783.
47. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
48. Mochizuki S, Dahlof B, Shimizu M, Ikewaki K, Yoshikawa M, Taniguchi I, et al. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet 2007; 369:1431-1439.
49. Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370:829-840.
50. Malacco E, Omboni S, Volpe M, Auteri A, Zanchetti A. Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly patients with mild to moderate essential hypertension: the ESPORT study. J Hypertens 2010; 28:2342-2350.
51. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358:1887-1898.
52. Haller H, Ito S, Izzo JL Jr., Januszewicz A, Katayama S, Menne J, et al. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 2011; 364:907-917.
53. Disertori M, Latini R, Barlera S, Franzosi MG, Staszewsky L, Maggioni AP, et al. Valsartan for prevention of recurrent atrial fibrillation. N Engl J Med 2009; 360:1606-1617.
54. Tocci G, Ferrucci A, Guida P, Avogaro A, Comaschi M, Corsini A, et al., Committee obotES. Use of electronic support for implementing global cardiovascular risk management: analysis of the results of the EFFECTUS (Evaluation of Final Feasible Effect of Control Training and Ultra Sensitisation) educational programme. High Blood Press Cardiovasc Prev 2010; 17:37-47.
55. Stergiou GS, Parati G. How to best monitor blood pressure at home? Assessing numbers and individual patients. J Hypertens 2010; 28:226-228.
56. Stergiou G, Parati G. Further insights into the 24-h blood pressure profile by home blood pressure monitoring: the issue of morning hypertension. J Hypertens 2009; 27:696-699.
57. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 2002; 20:1461-1464.